Recent studies have implicated local inflammation and complement activation in the pathogenesis of age-related macular degeneration (AMD) and geographic atrophy. It has been suggested that amyloid beta is linked to these local inflammatory processes, identifying it as a potential interventional target to reduce inflammatory response and limit the progression of geographic lesions. This video briefly details data presented at this year’s ARVO congress, in Seattle, US (Wednesday 04 May 2016, 09:00-09:15 PM, Session 403). Authors Lashkari et al. from the Schepens Eye Institute, USA concluded that the amyloid beta plasma levels were significantly higher in patients with geographic atrophy, supporting the hypothesis that targeting amyloid beta may help reduce the progression of geographic atrophy.

Related Articles